KPJ Healthcare Berhad (KPJ), focusing on its financial performance for the second quarter of 2024 (2Q24) and the first half of 2024 (1H24). The report also provides an outlook on the company’s future performance and investment recommendations. Here’s a detailed summary with elaborations:
Financial Performance Overview (2Q24 and 1H24)
- Revenue Growth: KPJ Healthcare reported strong revenue growth of 18.5% year-on-year (YoY) in 2Q24, reaching MYR 930.6 million. The revenue for 1H24 also saw a significant increase, up 14.9% YoY to MYR 1.84 billion. This growth was primarily driven by higher inpatient volumes, improved bed utilization, and strong demand from both domestic and foreign patients.
- EBITDA and Net Profit:
- EBITDA for 2Q24 increased by 18.7% YoY to MYR 219.2 million, and for 1H24, it grew by 11.8% YoY to MYR 413.3 million. The improvement in EBITDA was supported by higher revenue and cost optimization measures.
- Net Profit for 2Q24 rose significantly by 61.9% YoY to MYR 75.9 million, while the net profit for 1H24 increased by 49.9% YoY to MYR 147.3 million. The strong growth in net profit was also boosted by a one-time gain of MYR 40 million from the sale of its aged care business.
Strategic Initiatives and Growth Drivers
- Expansion of Bed Capacity: KPJ is actively expanding its bed capacity to meet the growing demand for healthcare services. The company plans to add approximately 350 to 1,000 beds by FY26, including the launch of a new 60-bed hospital in Kuala Selangor by 1H25. This expansion is expected to further drive revenue growth and enhance operational efficiency.
- Health Tourism: KPJ has been benefiting from the increasing trend in health tourism, with the highest revenue contribution from this segment since 2016. In 1H24, health tourism accounted for 5.8% of total revenue. The company is well-positioned to capture a larger share of the foreign patient market, contributing to its overall revenue growth.
- Cost Optimization: KPJ continues to focus on improving its margins through various cost optimization initiatives. This includes better management of operating expenses and enhancing the efficiency of its healthcare services, which are expected to support sustainable profit growth.
Outlook and Investment Recommendation
- Positive Earnings Outlook: The report is optimistic about KPJ’s future earnings, projecting a continued uptrend driven by increased patient visits, bed capacity expansion, and growth in health tourism. The analysts have revised up their FY24E and FY25E net profit forecasts by +12% and +7%, respectively, reflecting confidence in KPJ’s ability to deliver strong financial performance.
- Upgrade to Buy: The target price for KPJ has been raised to MYR 2.10 from the previous MYR 1.42, based on an unchanged Sum-of-Parts (SOP) valuation. The report upgrades KPJ to a “BUY” rating, citing the favorable risk-reward ratio and the company’s strong operational potential and sector outlook.
Risks and Considerations
- Operational Risks: The report highlights potential risks, including the longer-than-expected gestation period for new hospitals to achieve EBITDA breakeven, which could drag margins. There is also concern about the shortage of nurses and skilled medical professionals, which could dampen KPJ’s expansion plans and moderate revenue growth.
- Competition: Rising competition from other private hospital operators poses a challenge to KPJ, especially in capturing market share in both the domestic and foreign patient segments.
Conclusion
KPJ Healthcare Berhad is well-positioned for growth, supported by strong demand for healthcare services, strategic expansion of its hospital network, and increasing contributions from health tourism. The company’s focus on cost optimization and capacity expansion is expected to drive continued earnings growth. The “BUY” recommendation reflects the company’s solid fundamentals and the potential for significant upside in its share price.
Thank you
